These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 3754490

  • 1. Phase II study of combination chemotherapy with etoposide and amsacrine in relapsed adult leukemia.
    Abrams RA, Hanson G, Hansen RM, Anderson T.
    Cancer Treat Rep; 1986 Apr; 70(4):535. PubMed ID: 3754490
    [No Abstract] [Full Text] [Related]

  • 2. Amsacrine alone or in combination with 5-azacytidine and etoposide in refractory or relapsed acute non lymphoblastic leukemia (ANLL).
    Carella AM, Santini G, Martinengo M, Nati S, Giordano D, Congiu A, Cerri R, Damasio E, Risso M, Rossi E.
    Haematologica; 1985 Apr; 70(1):39-43. PubMed ID: 2408974
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Amsacrine with high-dose cytarabine in acute leukemia.
    Zittoun R, Bury J, Stryckmans P, Lowenberg B, Peetermans M, Rozendaal KY, Haanen C, Kerkhofs M, Jehn U, Willemze R.
    Cancer Treat Rep; 1985 Dec; 69(12):1447-8. PubMed ID: 3841026
    [No Abstract] [Full Text] [Related]

  • 7. Phase II trial of amsacrine plus intermediate-dose Ara-C (IDAC) with or without etoposide as salvage therapy for refractory or relapsed acute leukemia.
    Sung WJ, Kim DH, Sohn SK, Kim JG, Baek JH, Jeon SB, Moon JH, Ahn BM, Lee KB.
    Jpn J Clin Oncol; 2005 Oct; 35(10):612-6. PubMed ID: 16172175
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of acute leukemia with amsacrine and high-dose cytarabine.
    Arlin ZA, Gaddipati J, Ahmed T, Mittelman A, Friedland M, Rieber E.
    Cancer Treat Rep; 1985 Sep; 69(9):1001-2. PubMed ID: 3839713
    [Abstract] [Full Text] [Related]

  • 12. Combination amsacrine and high-dose cytosine arabinoside in acute leukemia.
    Arlin ZA.
    J Clin Oncol; 1985 Jan; 3(1):128. PubMed ID: 3838101
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Phase II trial of amsacrine in patients with hepatoma: a Cancer and Leukemia Group B study.
    Amrein PC, Richards F, Coleman M, Poulin RF, Holland JF, Weinberg V, Perry M.
    Cancer Treat Rep; 1984 Jun; 68(6):923-4. PubMed ID: 6329510
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Phase II study of amsacrine in metastatic renal cell carcinoma: a Cancer and Leukemia Group B study.
    Amrein PC, Coleman M, Richards F, Poulin RF, Berkowitz I, Kennedy BJ, Green M, Herschkopf R, Rafla S.
    Cancer Treat Rep; 1983 Nov; 67(11):1043-4. PubMed ID: 6688967
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. High-dose AMSA and autologous bone marrow transplantation in relapsed acute leukemia.
    Zander AR, Vellekoop L, Dicke KA, Keating MJ, McCredie KB, Legha SS, Spitzer G, Verma D, Bodey GP.
    Cancer Treat Rep; 1982 Nov; 66(11):1991-2. PubMed ID: 6754077
    [No Abstract] [Full Text] [Related]

  • 20. High-dose amsacrine (AMSA) therapy of relapsed and refractory adult acute nonlymphocytic leukemia. A phase II study.
    Cassileth PA, Lyman GH, Bennett JM, Glick JH, Oken MM.
    Am J Clin Oncol; 1984 Aug; 7(4):361-3. PubMed ID: 6547566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.